Influenza Vaccine Dose and Dementia Outcomes US claims data compare high- vs standard-dose formulations in patients aged 65 years or more over 3 years of follow-up By Kathryn Wighton April 10, 2026 3 min Conexiant Share Summary Takeaways Listen Insight Report Clinical Scorecard Quiz Poll Top Institutions Top Thought Leaders